chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse event; Vaccine was expired on 10-JUN-2023 which was administred on 14-JUL-2023; Patient received expired Moderna Bivalent vaccine as first dose of primary series; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 10-JUN-2023 which was administred on 14-JUL-2023), WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series) and NO ADVERSE EVENT (No adverse event) in an 81-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Jul-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 14-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 10-JUN-2023 which was administred on 14-JUL-2023) and WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 10-JUN-2023 which was administred on 14-JUL-2023), WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 10-JUN-2023 which was administred on 14-JUL-2023) and WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series).    No concomitant medication was reported.  Date the vial initially stored in the refrigerator 13-JUL-2023.Expiration date was reported as 10-JUN-2023. The vial did not undergo any temperature excursions. No treatment information was reported.
This spontaneous report as received from a physician refers to a 58 year old female patient. On 03-MAR-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (route, dose and lot # not reported). The physician reported that on 03-MAR-2015, about 5 hours after vaccination, the patient experienced severe pain around injection site. The physician reported there was no swelling or redness around injection site but just plain was reported by patient. It was unknown if PNEUMOVAX 23 dose was the patient's first dose or if patient had any previous dose of PNEUMOVAX 23. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Progress Notes PA-C (Physician Assistant) ? ? Family Medicine Cosign Needed Expand AllCollapse All    COVID VACCINE CLINIC 3/22/2021      Date:  3/22/2021                                                                                           MRN:  3150851     Subjective Patient is a 54 y.o. female who was seen at Vaccine Clinic today for her first  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the right deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience hives.  She denied difficulty breathing, difficulty swallowing, wheezing and throat tightness.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to rapid progression of symptoms, respiratory distress and skin changes.     ALLERGY REVIEW OF SYSTEMS:  Patient complains of hives (1 hive on chest)   Patient denies chills, facial swelling, cough, chest tightness, shortness of breath, wheezing, dizziness and headaches       Previous Reactions: Denies prior reaction to vaccines    Objective    Vitals Vitals:   03/22/21 0828 03/22/21 0846 BP: (!) 153/87 (!) 141/69 Pulse: 52   SpO2: 100%        Physical Exam Constitutional:      Appearance: Normal appearance.  HENT:     Head: Normocephalic.     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear. No posterior oropharyngeal erythema.     Comments: No swelling or lips or tongue.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.     Breath sounds: Normal breath sounds. No wheezing or rales.  Skin:    General: Skin is warm and dry.     Comments: +erythematous hive on anterior chest.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.        Assessment/Plan  Treatment included: antihistamines Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Local reaction (arm pain, bleeding/bruising, mechanical irritation, localized rash) and Systemic reaction (hypoglycemia, hypotension, generalized rash)  Encouraged patient to take benadryl prior to getting her second vaccination.  PA-C Electronically Signed 3/22/2021 8:55 AM
It started with mild coughing and sneezing. It got progressively worse. The coughing was severe. The sneezing was intense. I took an COVID-19 test on Monday. It was a weak positive, but it was positive. On Wednesday, I took another COVID-19 test. The line was intensely pink. At that point, I called the doctor and had a telehealth visit. She prescribed PAXLOVID. I started taking it Wednesday evening. Yesterday afternoon, the symptoms were mild, but I had a severe sore throat. I took MOTRIN. Today, I'm hoarse and the sore throat is almost gone. My coughing and sneezing stopped. My blood oxygen and pulse look good.
Fever following rotavirus injection. Ongoing crying for several days. 11 days later diarrhea (over 15 diapers in 24 hours) with blood in stool.
COVID Vaccine Breakthrough Case  Moderna Dose 1 2/29/21 (023M20A) COVID Positive 12/14/21  12/18/21: The patient is a 74 year old male with a past medical history of congestive heart failure LVEF 50-55%, COPD, type 2 diabetes mellitus, Parkinson's disease and tobacco use. The patient presented to ED with complaints of generalized weakness for the past 1 week.  The patient was diagnosed with COVID on 12/14.  He has complaints of a mild cough, fever, nausea without vomiting, decreased appetite and oral intake.  He denies any chest pain.  He denies any shortness of breath.  He received 1 COVID-19 vaccine back in February.  He lives at home at baseline with his wife and daughter.  He is ambulatory feel walker.  Patient has become progressively weaker since being diagnosed with COVID and has been unable to ambulate and care for himself. Per chart review his wife and daughter are not able to care for him at this time.  He does have a indwelling Foley catheter at that this time but he is unaware why.  On arrival to ED patient's vital signs were stable. Laboratory findings were significant for hypokalemia 3.0. CKD stage G 3A creatinine 1.31.  ProBNP 4221. D-dimer 1.52.  CT chest no PE.  Mild ground-glass airspace disease in the right lung suggesting mild pneumonitis.  Possible mucus plugging in the left lower lobe segmental bronchus. Emphysema.  Levaquin initiated in ED.  Decadron given. Zofran given.  Potassium 40 mEq 2 tabs p.o. given.  IV fluid resuscitation was given with NS 0.9% 1.5 L bolus.  12/21/21: As noted patient presented with complaints of generalized weakness for week prior to arrival was diagnosed with the COVID-19 on 12/14.  Only received 1 dose of vaccine in February.  Was found to pneumonia on imaging, likely viral in nature, vitamin C and zinc vitamin-D nebulizer treatments and IV fluids.  Patient however did not require any supplemental oxygen.  Did not qualify for remdesivir, steroids.  Gradually improved p.o. intake improved working with therapy was able to ambulate.  P.o. intake improved,  IV fluids were discontinued.  Therapy recommended home with home health supportive cares.  All ED in RTC precautions were provided to patient, endorses understanding and in agreement with plan as outlined.
pt. given Flu Mist on 1/10/08 despite contraindication of asthma.  Clinical staff verified questions with mother, but did not check the chart.  When she checked the chart, she found that patient had a contraindication of asthma.
since he got the 1st dose he was tested positive; since he got the 1st dose he was tested positive; This is a spontaneous report from a Pfizer Sponsored Program by contactable consumer (patient). A male patient of unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 01Mar2021 as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 17Mar2021, since he got the first dose, he was tested positive for virus. The patient wanted to know whether he could receive second dose on 23Mar2021 (More than 21 days). The outcome of the events was unknown.
Varicella and MMR vaccines given on 8-18-09. Child developed mild redness at site of Varicella vaccine only on 8-19-09, called our office about it on 8-25-09, resolved after a few doses of Benadryl on 8-26-09.
Information has been received from a 25 year old female consumer with no pertinent medical history or drug reactions/allergies who in January 2007, was vaccinated with a first dose of GARDASIL (lot number unknown) and in March 2007 was vaccinated with a second dose of GARDASIL (lot number unknown). Concomitant therapy included hormonal contraceptives (unspecified). The consumer reported that the next day after she received her first and second dose of the vaccinations she had a sharp muscle pain that ran through the left arm all the way up and through her "next" on the left side. The pain lasted for about a month after the injection. The patient recovered about a month after each injection. Medical attention was sought. Additional information has been requested. This is in follow-up to repport (s) previously submitted on 7/16/2007. Follow-up information was received on 9-JUL-2007 via telephone. The patient wanted to know if she should get the third dose of GARDASIL vaccine. No additional adverse event information was provided. Additionla information has been requested.
pt has panic attack after receiving covid vaccine. pt was with her spouse. we gave her water to drink and tried to calm her down. after 10-15 minutes she was ok and walked out of store with her spouse.
Information has been received concerning a 5 year old male pt who on 04-JUN-2001 was vaccinated with a dose of varicella virus vaccine live (lot number 637668/1607K). There was no illness at the time of vaccination. There were no adverse events following prior vaccinations. On 14-MAR-2004, the pt developed a "rash - maculopapular erythematous to vesicular rash" all over the body of approximately 35 lesions. It was noted that the rash was itchy with one crusted lesion. There were no laboratory diagnostic tests performed. Additional information has been requested.
Itching skin 24 hours after vaccine, developed hives on arms, neck and face 48 hours after vaccine.
decrease appetite; feeling "sicky", not throwing up; This is a spontaneous report from a contactable consumer reported for her mother.   A 84-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unknown route on unknown date in Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. In Jan2021 the patient experienced feeling "sicky", not throwing up and decrease appetite. The outcome of the events was recovering. The patient received treatment with zofran.   Information on the lot/batch number has been requested.
12/29/09 Pt arrived to hospital via ambulance with c/o light headedness, dizziness, blurred vision and left arm pain where she received H1N1. Sx's occurred after waking up in am. C/o chest pain as well. ER diagnosed pt with vaccination side effect - Rule out, viral syndrome - rule out. Per mom 1/14/10 pt recovered.
Swelling; Redness; Fatigue; This case was reported by a consumer via call center representative and described the occurrence of swelling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. In November 2019, unknown after receiving Shingrix, the patient experienced swelling, erythema and fatigue. On an unknown date, the outcome of the swelling, erythema and fatigue were recovered/resolved.   It was unknown if the reporter considered the swelling, erythema and fatigue to be related to Shingrix.  Additional case details were reported as follows: This case was reported by patient herself. The age at vaccination was not reported. The events occurred 5 months prior to the date of reporting and lasted for 3 days. No further details were provided.
This spontaneous report as received from a nurse refers to a 10 unspecified patients of unknown age and unknown gender. The unspecified patients pertinent medical history was not reported. On an unknown date, the patients were vaccinated with a dose of improperly stored VAQTA (lot # K019560 and expiry date: 02-JUN-2017). No adverse effects were reported. No product quality complaint (PQC) was reported for VAQTA. This is one of the several reports from the same reporter. Additional information has been requested.
Shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 9DE73, expiry date 6th December 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at administration was not reported. The patient received Shingrix and developed Shingles. Reporter cnsented to follow up.
This case was reported by a pharmacist and described the occurrence of supraclavicular lymph node in an adult female subject who was vaccinated with Influenza vaccine (GlaxoSmithKline). On an unspecified date the subject received a dose of Influenza vaccine (unknown). At an unspecified time after vaccination with Influenza vaccine, the subject experienced supraclavicular lymph node. The subject received FLUARIX or FLULAVAL. The reporting pharmacist did not have time to give full details for this report. At the time of reporting the outcome of the event was unspecified.
I woke up feeling like I was in a Fog around 0530. I felt drugged and sedated. I work in an inpatient Pharmacy, that morning I worked in the sterile IV room. I reported to work at 0630. I told me coworkers how I felt. They asked me if I should be working, I told them I was fine. As the morning progressed my mind grew more frenzied, more sporadic. I spiraled, I couldn't maintain thought patterns, I couldn't think straight. As 0800 came, I knew that there was a strong possibility that I could make some mistakes and took a break and sat down in the hospital library. It didn't help. I grew more frantic and foggy. Around 1100 I left work, my coworkers asked me if I was ok to drive. I told her I was fine, it was only two and a half miles to home. I shouldn't have driven. I drove frantic that I was going to crash and sure that someone was in my blind spot as i switched lanes. I got home safely, kicked off my shoes, took a Xanax that I have prescribed for Panic attacks ( Since i had been fighting one off for about 4 hours at that point) and fell into bed, where i stayed in the same position for 5 hours, by 2000 that night I was still feeling foggy, but the anxiety was still there, though not as severe.   It is now Monday after the test and I still feel elevated anxiety levels, though less of the fog. If I had not had the xanax at home I would have admitted myself to the ER.
Began - General weakness, body aches, chills 12 hours later - 102 fever, full body/joint aches, chills 24 hours later - above continued 40 hours later - symptoms subsided fever came down below 100 minimal aches, etc 48 hours later - 102 fever, no body ache, chest/throat tightness (trouble deep breath), chills (considered urgent care) 64hours later - temp consistently normal bouts of chest tightness occasionally (believe fully recovered)  Began regiment of Tylenol (500mg) every 4-6 hours (as close to 6 as possible) w inbuprphin  (200mg) as needed (occasionally instead of Tylenol). Neither medication worked for all symptoms (Tylenol better for fever and chest tightness ibuprophin better for body aches)
Two days after the first Vaccine I was mowing the yard it was warm suddenly i started feeling strong  sharp needle like feelings in my chest,  back, shoulders , neck . I went into the shade to rest it took a couple minutes for it to subside . I checked my pulce it was at 106 and gradually went down . I have been in construction for over 45 years and have worked hard in the sun and have never expirienced  this. These episodes dont just happen in the sun  . When i went to get my second dose on 01/10/2021  it was warm in the building. and when the nurse asked me if i had experienced  side affects and i started to explain  and an episode started right then . it seems that anxiety can bring it on as well as exertion . it was coming on strong so i refused the vaccine. My dr has no answers
Instant reaction - swelling - went home with an ice bag on it - got a large lump underneath the swelling. Painful arm all way down to fingers - got ugly large black and blue - then it began to get red down to elbow. Give medicine at another doctor office on my third visit - Cephalexin 500mg. After looking at the red marks going down my arm said he did not like the looks of the arm. Put a circle around it with a black marker pen and said if the red moved out of those marks I should go to th Emergency Room at the hospital that night. He then came in the next day - Saturday to look at it and it had not gotten any bigger as I had gone directly to the pharmacist and started the prescription medicine immediately. It then started to improve very slowly but it took about ten days or so for the black and blue and red marks to go away. I still have a little lump at the injection point and I still have some residual pain in my arm when I go to my senior exercises. I do notice since this injection I am having pain across my shoulder and up the back of my neck a good deal of the time which I never ever had before. I had 4 office visit the first for blood pressure checkup and received vaccine the rest for checking my arm (Oct 13,17,21,22). I have had tetanus injections before alone and never had any type of reaction to them but I had the diphtheria injection in grade school and had a bad reaction but the doctor just laughed and said that was more than 60 years ago.
Pneumonia; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PNEUMONIA (Pneumonia) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criterion medically significant). At the time of the report, PNEUMONIA (Pneumonia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included unspecified antibiotics. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
T to 101.6 /w temporay relief /w Tylenol from 20Feb-24Feb91, chest congestion & worsening cough 24Feb91.Saw FMD 25Feb91.Fluid in lt ear & possible bronchitis. Took Pediazole&cough syrup.Diarrhea&vomiting 27Feb91 to 7-830 pm.Seizure 27Feb91
Pt stated they had bone pain as a result of the shot.  It is persisting today.  They state the muscle doesn't hurt to the touch, but he experiences bone pain when doing push ups and weight lifting
This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE RIGIDITY (the area where she got the injection is buffed), VACCINATION SITE WARMTH (the area where she got the injection is warm) and VACCINATION SITE SWELLING (the area where she got the injection is swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.  No Medical History information was reported. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced MUSCLE RIGIDITY (the area where she got the injection is buffed), VACCINATION SITE WARMTH (the area where she got the injection is warm) and VACCINATION SITE SWELLING (the area where she got the injection is swollen). At the time of the report, MUSCLE RIGIDITY (the area where she got the injection is buffed), VACCINATION SITE WARMTH (the area where she got the injection is warm) and VACCINATION SITE SWELLING (the area where she got the injection is swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment information was reported.
Presented at clinic with presumed vaccine failure.  Diagnosis: Varicella on 01/24/04.
Pt developed rash and infection around injection site. Pt went to see MD, was prescribed Prednisone.
Patient brought to medical monitoring via wheelchair. profusely sweating, disoriented. assisted to cot. legs elevated. slowly progressed to sitting then ambulated independently to general population. discharge @ 2:45pm.
Information has been received concerning a case in litigation regarding a male child who was vaccinated IM with hep B vaccine recombinant on 6/16/97 (lot 622408/0064E) and 1/19/98 (lot 624804/1168E). He was also inoculated with three IM doses of Tetramune on 6/16/97 (lot 440765), 9/8/97 (lot 446770), and 11/7/97 (lot 447832); three IM doses of HIB conjugate vaccine (HIbTITER) on 6/16/97 (lot M300PN), 9/8/97 (lot M215RD) and 11/7/97 (lot M165RH); and a single IM dose of diphtheria toxoid/pertussis vaccine/teta (unk brand name) (lot 0932710) on 7/23/98. It is alleged that between the age of 18 to 36 months, as a result of the accumulation of mercury contained in the vaccinations as a preservative (Thimerasol), the pt suffered mercury toxicity and devastating, permanent, neurological injuries caused by mercury toxicity. Upon internal review, the devastating, permanent, neurological injuries caused by mercury toxicity were considered to be other important medical events (OMIC). Additional info is expected.
Information has been received from a nurse referring to an unspecified number of patients of unknown ages and gender. On unknown dates the patients were vaccinated with a dose of VARIVAX (Merck) (lot#, expiration date, dose, strength and route were not reported) or PROQUAD (lot#, expiration date, dose, strength and route were not reported) which exposed to a maximum temperature of -6.2C for a total time of 5.5 hours. No adverse effects were reported. It was unspecified if the patient sought medical attention. Additional information has been requested.